A2A Pharmaceuticals, Inc.

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 25% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
A2A Pharmaceuticals, Inc.'s trades of Biomea Fusion Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-02 2023-06-01
S Sale
16,657 +47.8%
140.62
US$1,576,900 		16,657 +47.8% 140.62 US$1,576,900
2023-06-02 2023-05-31
S Sale
37,569 +15.1%
353.34
US$3,054,857 		37,569 +15.1% 353.34 US$3,054,857
2023-05-19 2023-05-19
PrS Proposed sale
17,895
52.65
US$276,247 		17,895 52.65 US$276,247
2023-05-17 2023-05-12
S Sale
25,000 -0.7%
33.84
US$846,000 		25,000 -0.7% 33.84 US$846,000
2023-05-10 2023-05-09
S Sale
150,000 -3.9%
34.50
US$5,175,720 		150,000 -3.9% 34.50 US$5,175,720
2023-05-10 2023-05-08
S Sale
100,000 -2.6%
33.99
US$3,399,310 		100,000 -2.6% 33.99 US$3,399,310
2023-04-27 2023-04-27
PrS Proposed sale
400,000
30.00
US$12,000,000 		400,000 30.00 US$12,000,000
2023-04-26 2023-04-20
S Sale
200,000 -4.9%
29.12
US$5,823,760 		200,000 -4.9% 29.12 US$5,823,760
2023-04-20 2023-04-20
PrS Proposed sale
200,000
27.75
US$5,550,000 		200,000 27.75 US$5,550,000
2022-07-25 2022-07-21
S Sale
34,658 -0.8%
11.21
US$388,516 		34,658 -0.8% 11.21 US$388,516
2022-06-28 2022-06-24
S Sale
34,658 -0.8%
11.76
US$407,578 		34,658 -0.8% 11.76 US$407,578